Federal Register / Vol. 63, No. 73 /Thursday, April 16, 1998 / Notices 18921

meal as a color additive in salmonid fish

feeds.

FOR FURTHER INFORMATION CONTACT:

Aydin O ̈ rstan, Center for Food Safety

and Applied Nutrition (HFS–215), Food

and Drug Administration, 200 C St. SW.,

Washington, DC 20204, 202–418–3076.

SUPPLEMENTARY INFORMATION: Under the

Federal Food, Drug, and Cosmetic Act

(sec. 721(d)(1) (21 U.S.C. 379e(d)(1))),

notice is given that a color additive

petition (CAP 8C0256) has been filed by

Cyanotech Corp., 73–4460 Queen

Kaahumanu Hwy., #102, Kailua-Kona,

HI 96740. The petition proposes to

amend the color additive regulations to

provide for the safe use of

Haematococcus algae meal as a color

additive in salmonid fish feeds.

–The agency has determined under 21

CFR 25.32(r) that this action is of a type

that does not individually or

cumulatively have a significant effect on

the human environment. Therefore,

neither an environmental assessment

nor an environmental impact statement

is required.

Dated: March 20, 1998.

Laura M. Tarantino,

Office of Premarket Approval, Center for Food

Safety and Applied Nutrition.

[FR Doc. 98–10032 Filed 4–15–98; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 98F–0226]

Nalco Chemical Co.; Filing of Food

Additive Petition

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that Nalco Chemical Co. has filed a

petition proposing that the food additive

regulations be amended to provide for

the safe use of disodium or dipotassium

fluorescein for use in boilers where

steam may contact food.

DATES: Written comments on the

petitioner’s environmental assessment

by May 18, 1998.

ADDRESSES: Submit written comments

to the Dockets Management Branch

(HFA–305), Food and Drug

Administration, 12420 Parklawn Dr.,

rm. 1–23, Rockville, MD 20857.

FOR FURTHER INFORMATION CONTACT:

Paulette M. Gaynor, Center for Food

Safety and Applied Nutrition (HFS–

215), Food and Drug Administration,

200 C St. SW., Washington, DC 20204,

202–418–3079.

SUPPLEMENTARY INFORMATION: Under the

Federal Food, Drug, and Cosmetic Act

(sec. 409(b)(5) (21 U.S.C. 348(b)(5))),

notice is given that a food additive

petition (FAP 7A4539) has been filed by

Nalco Chemical Co., One Nalco Center,

Naperville, IL 60563–1168. The petition

proposes to amend the food additive

regulations in 21 CFR 173.310 to

provide for the safe use of disodium or

dipotassium fluorescein for use in

boilers where steam may contact food.

The potential environmental impact

of this action is being reviewed. To

encourage public participation

consistent with regulations promulgated

under the National Environmental

Policy Act (40 CFR 1501.4(b)), the

agency is placing the environmental

assessment submitted with the petition

that is the subject of this notice on

public display at the Dockets

Management Branch (address above) for

public review and comment. Interested

persons may, on or before May 18, 1998,

submit to the Dockets Management

Branch (address above) written

comments. Two copies of any comments

are to be submitted, except that

individuals may submit one copy.

Comments are to be identified with the

docket number found in brackets in the

heading of this document. Received

comments may be seen in the office

above between 9 a.m. and 4 p.m.,

Monday through Friday. FDA will also

place on public display any

amendments to, or comments on, the

petitioner’s environmental assessment

without further announcement in the

Federal Register. If, based on its review,

the agency finds that an environmental

impact statement is not required and

this petition results in a regulation, the

notice of availability of the agency’s

finding of no significant impact and the

evidence supporting that finding will be

published with the regulation in the

Federal Register in accordance with 21

CFR 25.40(c).

Dated: March 26, 1998.

Laura M. Tarantino,

Acting Director, Office of Premarket

Approval, Center for Food Safety and Applied

Nutrition.

[FR Doc. 98–10031 Filed 4–15–98; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Research Studies on Microbiological

Hazards Associated with the Food

Animal Production Environment

Including Animal Feeds; Availability of

Cooperative Agreements; Request for

Applications

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA), Center for

Veterinary Medicine (CVM) is

announcing the availability of research

funds for fiscal year (FY) 1998 to study

the microbiological hazards associated

with the food animal production

environment which includes animal

feeds. Approximately $1 million will be

available in FY 1998. FDA anticipates

making 6 to 12 Cooperative Agreement

awards at $100,000 to $200,000 per

award per year (direct and indirect

costs). Support for these agreements

may be for up to 3 years. The number

of agreements funded will depend on

the quality of the applications received

and the availability of Federal funds to

support the projects.

DATES: Submit applications by June 1,

1998. If the closing date falls on a

weekend, it will be extended to

Monday; if the date falls on a holiday,

it will be extended to the following

workday.

ADDRESSES: Application forms are

available from, and completed

applications should be submitted to:

Robert L. Robins, Grants Management

Officer, Division of Contracts and

Procurement Management (HFA–520),

Food and Drug Administration, 5600

Fishers Lane, Park Bldg., rm. 3–40,

Rockville, MD 20857, 301–443–6170.

(Applications hand-carried or

commercially delivered should be

addressed to the Park Bldg., 12420

Parklawn Dr., rm. 3–40, Rockville, MD

20852.)

FOR FURTHER INFORMATION CONTACT:

Regarding the administrative and

financial management aspects of

this notice: Robert L. Robins

(address above).

Regarding the programmatic aspects

of this notice: David B. Batson,

Center for Veterinary Medicine

(HFV–502), Food and Drug

Administration, 8401 Muirkirk Rd.,

Laurel, MD 20708, 301–827–8021.

SUPPLEMENTARY INFORMATION: FDA is

announcing the availability of funds for

FY 1998 for awarding cooperative